Literature DB >> 23900486

Interval-censored time-to-event and competing risk with death: is the illness-death model more accurate than the Cox model?

Karen Leffondré1, Célia Touraine, Catherine Helmer, Pierre Joly.   

Abstract

BACKGROUND: In survival analyses of longitudinal data, death is often a competing event for the disease of interest, and the time-to-disease onset is interval-censored when the diagnosis is made at intermittent follow-up visits. As a result, the disease status at death is unknown for subjects disease-free at the last visit before death. Standard survival analysis consists in right-censoring the time-to-disease onset at that visit, which may induce an underestimation of the disease incidence. By contrast, an illness-death model for interval-censored data accounts for the probability of developing the disease between that visit and death, and provides a better incidence estimate. However, the two approaches have never been compared for estimating the effect of exposure on disease risk.
METHODS: This paper compares through simulations the accuracy of the effect estimates from a semi-parametric illness-death model for interval-censored data and the standard Cox model. The approaches are also compared for estimating the effects of selected risk factors on the risk of dementia, using the French elderly PAQUID cohort data.
RESULTS: The illness-death model provided a more accurate effect estimate of exposures that also affected mortality. The direction and magnitude of the bias from the Cox model depended on the effects of the exposure on disease and death. The application to the PAQUID cohort confirmed the simulation results.
CONCLUSION: If follow-up intervals are wide and the exposure has an impact on death, then the illness-death model for interval-censored data should be preferred to the standard Cox regression analysis.

Entities:  

Keywords:  Competing risks; Cox model; Weibull model; cohort; dementia; interval censoring; longitudinal data; multistate model; penalized likelihood; semi-parametric illness-death model

Mesh:

Year:  2013        PMID: 23900486     DOI: 10.1093/ije/dyt126

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  28 in total

1.  A multi-state model based reanalysis of the Framingham Heart Study: Is dementia incidence really declining?

Authors:  Nadine Binder; James Balmford; Martin Schumacher
Journal:  Eur J Epidemiol       Date:  2019-10-14       Impact factor: 8.082

2.  Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage: A prospective study of diagnostic accuracy.

Authors:  Eric S Rosenthal; Siddharth Biswal; Sahar F Zafar; Kathryn L O'Connor; Sophia Bechek; Apeksha V Shenoy; Emily J Boyle; Mouhsin M Shafi; Emily J Gilmore; Brandon P Foreman; Nicolas Gaspard; Thabele M Leslie-Mazwi; Jonathan Rosand; Daniel B Hoch; Cenk Ayata; Sydney S Cash; Andrew J Cole; Aman B Patel; M Brandon Westover
Journal:  Ann Neurol       Date:  2018-05-16       Impact factor: 10.422

3.  The combined association of alcohol consumption with dementia risk is likely biased due to lacking account of death cases.

Authors:  Nadine Binder; Lisa Manderscheid; Martin Schumacher
Journal:  Eur J Epidemiol       Date:  2017-05-15       Impact factor: 8.082

4.  Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies.

Authors:  Jie Ding; Kendra L Davis-Plourde; Sanaz Sedaghat; Phillip J Tully; Wanmei Wang; Caroline Phillips; Matthew P Pase; Jayandra J Himali; B Gwen Windham; Michael Griswold; Rebecca Gottesman; Thomas H Mosley; Lon White; Vilmundur Guðnason; Stéphanie Debette; Alexa S Beiser; Sudha Seshadri; M Arfan Ikram; Osorio Meirelles; Christophe Tzourio; Lenore J Launer
Journal:  Lancet Neurol       Date:  2019-11-06       Impact factor: 44.182

5.  APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.

Authors:  Hugh C Hendrie; Jill Murrell; Olusegun Baiyewu; Kathleen A Lane; Christianna Purnell; Adesola Ogunniyi; Frederick W Unverzagt; Kathleen Hall; Christopher M Callahan; Andrew J Saykin; Oye Gureje; Ann Hake; Tatiana Foroud; Sujuan Gao
Journal:  Int Psychogeriatr       Date:  2014-02-24       Impact factor: 3.878

6.  Incidence of and Risk Factors Associated With Age-Related Macular Degeneration: Four-Year Follow-up From the ALIENOR Study.

Authors:  Valentine Saunier; Bénédicte M J Merle; Marie-Noëlle Delyfer; Audrey Cougnard-Grégoire; Marie-Bénédicte Rougier; Philippe Amouyel; Jean-Charles Lambert; Jean-François Dartigues; Jean-François Korobelnik; Cécile Delcourt
Journal:  JAMA Ophthalmol       Date:  2018-05-01       Impact factor: 7.389

7.  Change in Cardiovascular Health and Incident Type 2 Diabetes and Impaired Fasting Glucose: The Whitehall II Study.

Authors:  Rachel E Climie; Thomas T van Sloten; Marie-Cécile Périer; Muriel Tafflet; Aurore Fayosse; Aline Dugravot; Archana Singh-Manoux; Jean-Philippe Empana
Journal:  Diabetes Care       Date:  2019-08-15       Impact factor: 19.112

Review 8.  Examining the relationship between multidrug-resistant organism acquisition and exposure to antimicrobials in long-term care populations: a review.

Authors:  Michele L Shaffer; Erika M C D'Agata; Daniel Habtemariam; Susan L Mitchell
Journal:  Ann Epidemiol       Date:  2016-09-23       Impact factor: 3.797

9.  Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia.

Authors:  Cécilia Samieri; Marie-Cécile Perier; Bamba Gaye; Cécile Proust-Lima; Catherine Helmer; Jean-François Dartigues; Claudine Berr; Christophe Tzourio; Jean-Philippe Empana
Journal:  JAMA       Date:  2018-08-21       Impact factor: 56.272

10.  Cohort Differences in Cognitive Impairment and Cognitive Decline Among Mexican-Americans Aged 75 Years or Older.

Authors:  Brian Downer; Marc A Garcia; Mukaila Raji; Kyriakos S Markides
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.